Insurance · Deep dive

Accelerant Holdings

The specialty-insurance marketplace that Thoma Bravo is taking private for over $4B one year after its IPO — $20.25 a share, below the July 2025 IPO price of $21 — despite Q2 2026 revenue of $356.9M and 62.9% YoY growth.

well positioned

The Risk Exchange model is genuinely valuable capital-formation software with real network effects across 280 Members and $4.19B of 2025 exchange premium, but public markets punished the Hadron-shaped related-party disclosure and Thoma Bravo is buying the compounding at a discount that Wall Street was never willing to pay.

My take ★★ Very interesting ★ Interesting − Maybe ✗ Not interesting

Snapshot

Accelerant Holdings is a Cayman-domiciled, Atlanta- and Colchester-run specialty-insurance marketplace that operates the Accelerant Risk Exchange — software and paper that connects roughly 280 specialty managing general agents (“Members”) with reinsurers, insurers and ILS funds (“Risk Capital Partners”). Full-year 2025 exchange written premium reached $4.19B on a 51.3% gross loss ratio, improved from 54.3% in 2024 per the 4Q25 earnings release. Q2 2026 revenue was $356.9M, up 62.9% YoY, with $78.7M of net income and $0.36 diluted EPS per the Q2 2026 10-Q. Yet on August 13, 2026 Thoma Bravo announced a $4B+ take-private at $20.25/share — a 49% premium to the August 12 close but below the July 24, 2025 IPO price of $21. That gap is the story.

Founding story

Accelerant was launched in December 2018 by Jeff Radke, Chris Lee-Smith and Frank O’Neill — all three ex-Argo Group operators who had spent the prior decade watching specialty MGAs get squeezed between arm’s-length reinsurance capacity that did not understand their books and fronting carriers that treated them as commodity paper. Radke is a second-generation reinsurance kid whose father Jerry Radke worked in the industry; he studied finance and insurance at Wisconsin-Madison and rose through Argo’s global underwriting and reinsurance functions. Lee-Smith is a 30-year insurance-intermediary veteran (Argo Head of Alternative Distribution, Aon Head of Growth Strategies, COO of Willis, Change Management head at Guy Carpenter) who is ACII-certified.

Altamont Capital Partners backed the launch in 2019 and has been the majority owner throughout, holding roughly 79% of the vote at IPO and roughly 82% under the voting-and-support agreement filed with the Thoma Bravo merger on August 13, 2026. In January 2022 Altamont led a $190M+ growth round (Deer Park Road, MS&AD Ventures also participated). By late 2023 press coverage pegged Accelerant near a $2.4B valuation.

How it works

The Risk Exchange is three moving parts stitched together. First, MGAs bind specialty policies (contract surety, cyber, professional liability, warranty, small commercial P&C, marine, etc.) on paper issued by a licensed insurance carrier. That paper is provided either by Accelerant’s own regulated carriers (owned Underwriting subsidiaries) or, increasingly, by third-party “fronting” carriers — historically Hadron Specialty Insurance, and since 2025 a widening set including Hippo (a partnership announced with capacity for $500M+ of annual GWP by 2027, program starts October 2026 per Insurance Business), Incline P&C, and a Lloyd’s ARX Consortium formed in July 2026.

Second, the risk is placed with a portfolio of Risk Capital Partners — reinsurers, ILS funds, and increasingly third-party primary insurers taking direct exposure — through the Accelerant Risk Exchange’s data layer. Members feed underwriting data (submission-level, policy-level and claims-level) into Accelerant’s InsightFull platform, which runs on a Snowflake-anchored stack per company technical materials. Capital Partners see standardized, real-time performance dashboards; MGAs see referral queues and portfolio benchmarking; both sides transact against a common ledger.

Third, Accelerant runs an Underwriting Referral system and a portfolio-management workbench that decides, for any given submission, which panel of Capital Partners is best matched on line, geography, aggregate limits and appetite. When Accelerant does the matching, the Capital Partner pays a volume-based fee for sourcing, monitoring and reporting. That fee is the Exchange Services take rate, disclosed at roughly 8% of premium in the Q4 2025 investor materials.

Product and business overview

Accelerant reports three revenue segments. Exchange Services is the marketplace itself: fees the Capital Partners pay Accelerant for access to Member flow, monitoring, referrals and portfolio management. This is the “software / marketplace” segment investors care about — $334.9M of revenue in 2025, up ~50% YoY per Investing.com’s read of the Q4 2025 deck. MGA Operations captures net commission Accelerant retains on business flowing through Members, roughly $217M in 2025 with a stated ~18% net commission rate. Underwriting is the retained-risk portion — Accelerant’s own regulated carriers keeping some economic exposure on the book — $113M in 2025 with a stated ~4% underwriting margin. Combined 2025 segment revenue was reported at more than $1.0B.

The three-segment structure is the pitch: the more Accelerant can grow Exchange Services as a share of the mix, the more it looks like a data-and-fee software business (Kinsale/Ryan Specialty multiples) rather than a fronting carrier (Trisura/Palomar multiples). The Q4 2025 deck flagged that third-party (non-Hadron) participation had reached 40% of the mix — the direction of travel investors have to underwrite.

Business model and pricing

Take-rate stack, per company disclosure through 2025:

The percentage of direct commission revenue coming from unaffiliated third parties (i.e., not Hadron or Accelerant-affiliated paper) was 24% for full-year 2025, up from 10% in 2024 per the 10-K. That single number is the cleanest read of whether Accelerant is de-risking the related-party problem.

Traction over time

Market analysis

The US MGA market crossed roughly $128B of total premium in 2025 per Aon’s 2026 study (via Carrier Management), with MGA direct premium written of $102.6B, up 12% from 2024. The E&S / specialty segment is roughly $93B globally in 2025 with the US taking more than 62% share per Global Growth Insights. Both segments have grown at high-single- to low-double-digit rates for five straight years, driven by hardening rates in casualty, cyber, professional liability and property-catastrophe, plus a structural shift of small-commercial risk off admitted paper.

The tailwind that matters for Accelerant specifically: reinsurers and ILS funds have spent the past three years complaining that they cannot get transparent, high-frequency, submission-level data out of MGA programs. Accelerant is one of the only platforms that ingests that data and shows it back to Capital Partners in real time. That data asset — 280 Members’ worth of submissions, bindings, claims and reserve development — is what a strategic acquirer is paying for.

Competitive intel

Ryan Specialty Holdings (NYSE: RYAN) — the wholesale-brokerage-plus-underwriting-management incumbent Pat Ryan built after selling Aon Risk Services. Ryan operates delegated authority through Ryan Specialty Underwriting Managers and a growing binding-authority stack. Not a fronting-carrier competitor per se, but competes head-to-head for the MGA relationships that constitute Accelerant’s Member roster.

Bowhead Specialty Holdings (NYSE: BOW) — IPO’d May 2024. Bermuda-style specialty carrier writing casualty, professional liability and healthcare on its own paper with a founder-led team out of AIG. Investors read Bowhead as the clean-balance-sheet counterexample to Accelerant’s fronting-and-fees structure.

Skyward Specialty (Nasdaq: SKWD) and Kinsale Capital (NYSE: KNSL) — the reference public specialty carriers. Kinsale trades at premium multiples because its underwriting is clean, its expense ratio is industry-best and there is no related-party fronting to explain. Every Accelerant investor conversation eventually gets to “why not just own Kinsale?”

Truist Insurance Holdings and Amwins — Truist Insurance was sold by Truist Financial for a $15.5B EV in a February 2024 deal that closed May 2024 (Clayton Dubilier & Rice, Stone Point, Mubadala). Amwins sits at similar scale under Dragoneer, Genstar and PSPIB. Distribution muscle that dwarfs Accelerant; the strategic threat is one of these two builds or buys a competing MGA marketplace and cuts Accelerant out of the flow.

The fronting cohort — Trisura (TSX: TSU), State National (Markel), Clear Blue, Obsidian, IAT, Palomar (Nasdaq: PLMR) — the direct comp set. Trisura’s 2023 US reserve development cost roughly USD $60M and remains the cautionary tale that public markets recite whenever an Accelerant-style structure discloses a bad quarter.

Berkshire Hathaway Specialty, W.R. Berkley (NYSE: WRB), RLI (NYSE: RLI), Applied Underwriters, Argo — the specialty-carrier incumbents that can go direct to any Accelerant Member with pen-and-paper capacity terms that compress Accelerant’s fee.

Bishop Street, Coalition, Falvey, Vantage — the roughly 25 other US specialty / wholesale / MGA / fronting-carrier platforms CT Acquisitions tracks. Any one of them can decide to compete with Accelerant rather than sit inside its Exchange.

History and evolution

• December 2018 — Radke, Lee-Smith and O’Neill incorporate Accelerant in Cayman.
• 2019 — Altamont Capital Partners takes majority stake and provides launch capital.
• January 2022 — $190M+ growth round led by Altamont.
• 2023 — Press coverage pegs the company near a $2.4B valuation.
• October 2023 — Announces expansion into Canada.
• September 2025 — Post-IPO earnings disclosure reveals the extent to which third-party premium is fronted by Hadron Specialty Insurance (owned by Altamont). Stock drops roughly a third. The Insurer separately reports Accelerant is working on a revised business plan for a Lloyd’s syndicate after initial pushback.
• July 24, 2025 — IPO on NYSE as ARX at $21; opens at $28.50 for a $6.4B debut market cap.
• Late 2025 – 2026 — Diversification of fronting relationships: Hippo (October 2026 program start with $500M+ GWP target by 2027), Incline P&C (July 2026), Lloyd’s ARX Consortium (July 2026). USA Herald reports a Department of Insurance investigation is reportedly looking at the Accelerant / Hadron / Augment Risk related-party architecture.
• August 13, 2026 — Thoma Bravo Cherry Tree BidCo signs merger agreement to take Accelerant private at $20.25/share, $4B+ EV. Altamont’s ~82% voting stake signs support agreement. Go-shop through September 22, 2026; 6% per annum ticking fee if closing is delayed by regulatory approvals; expected close H1 2027.

What people say

The case for. Analysts who like the story point to the compounding: 62.9% Q2 2026 revenue growth, gross loss ratio improving to 51.3% for 2025, third-party commission share rising from 10% in 2024 to 24% in 2025, and $4.19B of exchange premium flowing through 280 Members. BMO Capital initiated at Outperform in 2025 per TipRanks’ The Fly. The Thoma Bravo bid at a 49% premium to the August 12 close is itself the strongest positive signal — a specialist software PE firm with insurance-tech pattern-matching from prior deals is paying $4B+ EV for what it clearly reads as a durable data-and-fee business trapped in a public-company disclosure regime that will not reward it.

The complaints. The Hadron related-party disclosure of September 2025 is the recurring bear-case anchor. Insurance Business reported the disclosure “tumbled” the shares; USA Herald reported a Department of Insurance investigation reportedly examining the Accelerant / Hadron / Augment Risk architecture. Analysts have flagged the complicated insurance structure and AI-driven disruption potential as overhangs; Raymond James cut the rating on limited upside pre-deal, and both Citizens and William Blair moved to Market Perform on the Thoma Bravo announcement. The 2025 GAAP net loss of ~$1.35B (largely IPO-related non-cash charges per Simply Wall St / 10-K) is the number bears wave around when the company talks about “compounding.” And the takeout below the IPO price is not what a company with 62.9% growth and a clean story would print.

Outlook: well positioned or at risk?

Well-positioned — but only in private hands. The exchange model has genuine, defensible network effects: the more Members feed Accelerant submission and claims data, the better the matching engine gets for Capital Partners, which brings more capacity, which attracts more Members. That flywheel is real and Kinsale-comparable, and Thoma Bravo is buying it at a discount to the IPO price precisely because public markets could not stomach the disclosure surface area — Hadron, Augment Risk, the DOI reportedly investigating, and a ~$1.35B GAAP net loss that no retail investor was ever going to parse against non-cash IPO-related items. Under Thoma Bravo, Accelerant can (a) unwind Hadron dependence quietly, (b) integrate Hippo, Incline and Lloyd’s capacity without quarterly-print anxiety, and (c) push Exchange Services from ~33% of revenue toward a majority mix without the market punishing every fronting-related headline. The risk that survives the take-private is durability: whether Members like Coalition or Bishop Street decide, once they hit scale, to source reinsurance directly and bypass the Exchange’s 8% take rate. That is the real long-run question — and it is why the 24%-to-third-party number matters more than the growth rate.

How to attack it

The wedge is transparent, single-sponsor fronting for MGAs that have outgrown Accelerant’s model, with a completely open reinsurer / ILS network and a data cooperative Members actually control. Accelerant’s structural vulnerability is that its Members do not own their own data; a well-funded attacker offering (a) API-native submission and claims ingestion where the MGA owns the export, (b) tokenized reinsurance placement that lets Members put capacity out to bid on every renewal, and (c) a published take-rate schedule with no related-party paper would appeal to any Accelerant Member that has crossed roughly $50M of GWP and started asking why they are paying 8% to someone who also owns their fronting carrier. Amwins, Ryan Specialty and Truist all have the distribution to do this if they choose to; a startup could do it Member-by-Member starting with the top 20 producers on the Accelerant platform, all of whom are public knowledge.

The exploitable weaknesses, each with a source: (1) the Hadron related-party disclosure of September 2025 (Insurance Business) that broke the stock and remains in the discovery record of a reported DOI investigation (USA Herald); (2) the ~$1.35B 2025 GAAP net loss (Simply Wall St / 10-K), which — non-cash or not — makes it hard to compete for Members on financial-partner narrative; (3) the concentration risk in the fronting stack (still ~60% Hadron-adjacent per the Q4 2025 deck implying only 40% third-party); (4) the Lloyd’s business-plan pushback (The Insurer, September 10, 2025) showing regulators are not rubber-stamping expansion; (5) the ~8% Exchange Services take rate — high enough that scaled Members have real incentive to disintermediate; and (6) the Cayman-domicile / voting-stake concentration (~82% Altamont) that Thoma Bravo is now inheriting, which any competitor can position against as governance friction that a founder-led MGA never has to deal with.

Adjacent-segment play

The same three-part stack — fronting paper, data cooperative, capital-matching engine — repackages naturally for at least four adjacent segments. First, captives and RRGs (risk retention groups): mid-market corporates increasingly want to retain their own risk with a fronting-carrier veneer for regulatory purposes, and an Accelerant-style exchange for captive-to-reinsurer matching does not exist at scale. Second, parametric and cat-adjacent lines (wildfire, flood, secondary perils): ILS funds want submission-level data from parametric MGAs and there is no marketplace equivalent — Coalition-style cyber and Kettle-style wildfire MGAs would plug directly in. Third, health-adjacent stop-loss and self-insured medical: the largest hidden MGA market in the US, currently sitting on legacy fronting relationships with Berkley, HCC and Voya, ripe for a data-and-capital exchange. Fourth, international specialty geographies — Latin America and Southeast Asia specialty markets look like the US in 2005, with fragmented MGAs and no capital-matching layer. Bishop Street, Vantage and Coalition have each dipped into adjacent verticals, but no one has bundled the exchange model itself into a new segment. The wedge generalizes because the primitive is not “specialty insurance” but “programmable capital-formation software for delegated underwriting” — every line where an MGA writes on someone else’s paper is fair game.

Sources and further reading

• Accelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo — Thoma Bravo, August 13, 2026.
• Accelerant Holdings Announces Pricing of Upsized Initial Public Offering — Accelerant, July 24, 2025.
• Accelerant’s upsized IPO to raise firm $426m — Reinsurance News, July 24, 2025.
• Accelerant valued at $6.4 billion in debut as insurance IPOs heat up — Reuters via Yahoo Finance, July 24, 2025.
• Accelerant shares tumble after disclosure of ties to fronting insurer — Insurance Business, September 2025.
• The Accelerant Insurance Holdings and Augment Risk Investigation — USA Herald, 2026.
• Accelerant Announces Fourth Quarter and Full Year 2025 Results — Accelerant, March 2026.
• Accelerant Q4 2025 presentation: strong beat, third-party mix hits 40% — Investing.com, March 2026.
• Accelerant Holdings Q2 2026: Revenue $356.9M, EPS $0.36 — 10-Q Summary — TradingView, August 2026.
• US MGA market swells to $128 billion as specialization reshapes distribution — Insurance Business / Aon 2026 MGA Study, August 2026.
• Why Is Accelerant Going Private Just One Year After Its IPO? — Motley Fool via Yahoo Finance, August 2026.